Drugs Made In America Acquisition II Corp. currently lacks significant business operations. Its core objective is to execute a business combination, which may take various forms such as a merger, an acquisition of assets or shares, a recapitalization, or a reorganization, with one or more other entities. The company was founded in 2024 and maintains its principal office in Fort Lauderdale, Florida.
| Price | $10.17 |
|---|---|
| Market cap | $647.83M |
| Sector | Financial Services |
| Industry | Financial - Conglomerates |
| Exchange | NASDAQ |
| 52-week range | 9.86-10.21 |
| Beta | 0.04 |
Explore DMII's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.